Participate Today
Save Lives Tomorrow!
Featured Study
NASH Trial
FOMAT is enrolling participants for a NASH Clinical Trial.
Non-alcoholic steatohepatitis (NASH) is a silent disease that often stays asymptomatic until advanced stages. It involves excess liver fat, leading to inflammation and damage over time. In early phases, it goes unnoticed, but as NASH advances, it can become cirrhosis, severely impairing liver function and risking complications. Early detection and action are vital to prevent NASH progression and protect liver health.
Which Clinical Trial Do You Want To Participate In?
Active Studies
Filter Trials By Status
Filter Trials By Location
Filter Trials By Age
Filter Trials by Condition
-
Ventura
Asthma Study
Asthma is a chronic condition that inflames and narrows the airways, causing difficulty breathing. Symptoms include coughing, wheezing, shortness of breath, and chest tightness.
Read more
Criteria & Qualifications: • Must be 12 years or older.
• Must have an Asthma diagnosis.
• Must be able to provide medical records.
Compensation: Up to $2,000 -
Camarillo, Oxnard
NASH Study
Nonalcoholic fatty liver disease (NAFLD) is a condition where fat accumulates in the liver. NASH, the more severe form, causes swelling and damage to the liver. Currently, there is no existing treatment for NASH.
Read more
Criteria & Qualifications: • Is at least 18 years of age or older.
• Inflammation and liver damage, also known as Nonalcoholic steatohepatitis (NASH).
• Must be weight stable for 6 months.
Compensation: Up to $3,000.